Doctor profile · Federal record
Dr. DEEPTHI KUNDURU, M.D
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · WILLIAMSVILLE, NY
- NPI 1801130182
- Accepts Medicare
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
115 FLINT RD
WILLIAMSVILLE, NY 142213058
(716) 626-7973
Credentials & registration
- NPI registered
- November 2012 — 14 yrs on file
- Profile last updated
- April 29, 2016
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #282640
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801130182. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,119
Distinct HCPCS
10
Medicare allowed
$69,180
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 282 | 126 | $119 | |
83036 |
Hemoglobin a1c level | 123 | 76 | $9 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 118 | 47 | $32 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 114 | 114 | $158 | |
36415 |
Insertion of needle into vein for collection of blood sample | 104 | 69 | $8 | |
82044 |
Urine microalbumin (protein) analysis | 93 | 62 | $6 | |
82570 |
Creatinine level to test for kidney function or muscle injury | 92 | 61 | $5 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 70 | 50 | $3 | |
96372 |
Injection of drug or substance under skin or into muscle | 51 | 12 | $13 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 32 | 22 | $86 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 61. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$38
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, Inc. | 1 | $22.68 | |
| Novo Nordisk Inc | 1 | $15.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,797
Patients
509
Total drug cost
$1,172,684
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 292 | 67 | $373,766 |
| Jardiance (Empagliflozin) | Brand | 250 | 55 | $195,270 |
| Levothyroxine Sodium | Generic | 174 | 47 | $2,274 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 148 | 50 | $1,678 |
| Metformin Hcl | Generic | 143 | 53 | $1,004 |
| Soliqua 100-33 (Insulin Glargine/Lixisenatide) | Brand | 130 | 33 | $143,458 |
| Mounjaro (Tirzepatide) | Brand | 127 | 30 | $158,659 |
| Trulicity (Dulaglutide) | Brand | 125 | 30 | $146,698 |
| Atorvastatin Calcium | Generic | 88 | 27 | $776 |
| Pioglitazone Hcl | Generic | 74 | 23 | $692 |